PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Ready to serve 15g GMP protein equivalent (0913205)
Presentation Product Chemical substance Chapter Items dispensed
Glytactin RTD 15 liquid (2 flavours)
0913205L0BBACAB
Glytactin ready to serve 15g GMP protein equivalent Ready to serve 15g GMP protein equivalent (0913205) Nutrition and Blood 82
Glytactin Complete 15 81g bars peanut butter
0913205L0BBABAA
Glytactin ready to serve 15g GMP protein equivalent Ready to serve 15g GMP protein equivalent (0913205) Nutrition and Blood 19
Glytactin RTD Lite 15 liquid (2 flavours)
0913205L0BBADAC
Glytactin ready to serve 15g GMP protein equivalent Ready to serve 15g GMP protein equivalent (0913205) Nutrition and Blood 13
Glytactin Complete 15 81g bars fruit frenzy
0913205L0BBAAAA
Glytactin ready to serve 15g GMP protein equivalent Ready to serve 15g GMP protein equivalent (0913205) Nutrition and Blood 7
Generic Glytactin Complete 15 81g bars
0913205L0AAAAAA
Ready to serve 15g GMP protein equivalent (0913205) Ready to serve 15g GMP protein equivalent (0913205) Nutrition and Blood No data available
Generic Glytactin RTD 15 liquid
0913205L0AAABAB
Ready to serve 15g GMP protein equivalent (0913205) Ready to serve 15g GMP protein equivalent (0913205) Nutrition and Blood No data available
Generic Glytactin RTD Lite 15 liquid
0913205L0AAACAC
Ready to serve 15g GMP protein equivalent (0913205) Ready to serve 15g GMP protein equivalent (0913205) Nutrition and Blood No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.